About EmVenio Research
EmVenio Research is a company based in Durham (United States) founded in 2020 was acquired by PCM Trials in February 2024.. EmVenio Research has raised $13.67 million across 2 funding rounds from investors including PCM Trials. EmVenio Research offers products and services including Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement. EmVenio Research operates in a competitive market with competitors including Landmark Health, Jet Health, Bright Health Group, Wellbox and WINFertility, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$13.67 M (USD)
in 2 rounds
-
Latest Funding Round
$9.17 M (USD), Series A
Dec 06, 2022
- Investors
-
Employee Count
Employee Count
-
Acquired by
PCM Trials
(Feb 23, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EmVenio Research
EmVenio Research offers a comprehensive portfolio of products and services, including Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Network of sites for conducting clinical trials in communities.
Flexible visits that bring clinical trials directly to participants.
Strategies for engaging and retaining diverse patient groups.
Community-based model for recruiting underrepresented populations.
Unlock access to complete
Funding Insights of EmVenio Research
EmVenio Research has successfully raised a total of $13.67M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $9.17 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $9.2M
-
First Round
First Round
(24 Aug 2022)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2022 | Amount | Series A - EmVenio Research | Valuation |
investors |
|
| Aug, 2022 | Amount | Series A - EmVenio Research | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EmVenio Research
EmVenio Research has secured backing from 1 investor. Prominent investors backing the company include PCM Trials. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers clinical trial networks and mobile services for sponsors worldwide.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EmVenio Research
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EmVenio Research
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Emvenio Research Comparisons
Competitors of EmVenio Research
EmVenio Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Landmark Health, Jet Health, Bright Health Group, Wellbox and WINFertility, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A medical group that delivers house calls and team-based interdisciplinary care to chronically ill population.
|
|
| domain | founded_year | HQ Location |
House call medical services are provided to patients at home.
|
|
| domain | founded_year | HQ Location |
Personalized care services are delivered in the healthcare sector.
|
|
| domain | founded_year | HQ Location |
Patient engagement and chronic care management services are provided.
|
|
| domain | founded_year | HQ Location |
Provider of family benefit solutions to employers, health plans, and individual patients
|
|
| domain | founded_year | HQ Location |
Patient engagement services are provided for healthcare providers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Emvenio Research
Frequently Asked Questions about EmVenio Research
When was EmVenio Research founded?
EmVenio Research was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is EmVenio Research located?
EmVenio Research is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Who is the current CEO of EmVenio Research?
Keith Henthorne is the current CEO of EmVenio Research.
Is EmVenio Research a funded company?
EmVenio Research is a funded company, having raised a total of $13.67M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.5M, raised on Aug 24, 2022.
What does EmVenio Research do?
EmVenio Research was founded in 2020 and is headquartered in Durham, United States. Operations focus on the healthcare sector, where clinical trials support is offered alongside patient engagement initiatives and general research services. These activities are conducted to facilitate medical studies and participant involvement. Leadership is provided by CEO Keith Henthorne, with services targeted at research organizations and healthcare providers in the region.
Who are the top competitors of EmVenio Research?
EmVenio Research's top competitors include Landmark Health, Melodi Health and Bright Health Group.
What products or services does EmVenio Research offer?
EmVenio Research offers Global Site Network, Mobile and Virtual Visits, Patient Engagement, and Community Engagement.
Who are EmVenio Research's investors?
EmVenio Research has 1 investor. Key investors include PCM Trials.